COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 140 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q1 2018. The put-call ratio across all filers is 1.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,972,081 | +37.9% | 132,979 | +32.6% | 0.08% | +33.9% |
| Q2 2023 | $2,155,426 | -22.4% | 100,299 | -13.3% | 0.06% | -26.3% |
| Q1 2023 | $2,776,291 | +1050.2% | 115,727 | +1012.3% | 0.08% | +985.7% |
| Q4 2022 | $241,373 | -34.1% | 10,404 | -43.9% | 0.01% | -75.9% |
| Q3 2021 | $366,000 | -23.4% | 18,549 | -8.1% | 0.03% | -34.1% |
| Q1 2021 | $478,000 | +220.8% | 20,174 | +78.3% | 0.04% | +238.5% |
| Q2 2019 | $149,000 | -67.2% | 11,316 | -62.3% | 0.01% | -59.4% |
| Q1 2019 | $454,000 | -20.1% | 29,985 | -9.4% | 0.03% | -11.1% |
| Q4 2018 | $568,000 | +12.7% | 33,081 | -3.2% | 0.04% | -5.3% |
| Q3 2018 | $504,000 | -16.1% | 34,192 | +45.3% | 0.04% | -9.5% |
| Q1 2018 | $601,000 | +132.0% | 23,534 | -8.4% | 0.04% | +27.3% |
| Q1 2017 | $259,000 | – | 25,705 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 1,887,332 | $34,840,000 | 5.65% |
| SECTORAL ASSET MANAGEMENT INC | 1,426,862 | $26,340,000 | 3.29% |
| Eventide Asset Management | 2,207,610 | $40,752,000 | 2.12% |
| Rock Springs Capital Management LP | 1,885,729 | $34,811,000 | 1.58% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 460,000 | $8,492,000 | 1.11% |
| Cormorant Asset Management, LP | 300,000 | $5,538,000 | 0.58% |
| HIGHLAND CAPITAL MANAGEMENT LP | 579,234 | $10,693,000 | 0.49% |
| TPG Group Holdings (SBS) Advisors, Inc. | 1,389,863 | $25,657,000 | 0.39% |
| NBW CAPITAL LLC | 69,050 | $1,275,000 | 0.34% |
| NEXT CENTURY GROWTH INVESTORS LLC | 144,972 | $2,676,000 | 0.33% |